Obstetrics & Gynaecology Search
Obstetrics & Gynaecology Obstetrics & Gynaecology
nausea%20-and-%20vomiting%20in%20pregnancy
NAUSEA & VOMITING IN PREGNANCY
Nausea & vomiting in pregnancy (NVP), commonly known as "morning sickness", affects 50-90% of pregnant women.
In most women, the condition manifests between the 4th-7th week after last menstrual period and resolves by the 16th week of gestation.
It manifests in a spectrum of severity from mild nausea to very rare life-threatening symptoms.
The etiology is multifactorial.
The pregnant woman's sense of well-being and her daily activities are greatly affected by nausea and vomiting; the physical and emotional impact often leads to anxiety and worry about the effect of the symptoms on the fetus and reduced job efficiency.

Nausea%20-and-%20vomiting%20in%20pregnancy Signs and Symptoms

Introduction

  • Nausea and vomiting in pregnancy (NVP), commonly known as “morning sickness”, affects 50-90% of pregnant women
  • In most women (60%), the condition manifests between the 4th-7th week after the last menstrual period and resolves by the 16th-20th week of gestation
    • About 9% of women have symptoms that last after the 16th week 

Definition

Hyperemesis Gravidarum

  • The most severe form of nausea and vomiting in pregnancy (NVP) affecting 0.3%-2% of all pregnant women
  • Persistent vomiting (>3x daily) may lead to dehydration and electrolyte disturbances, ketosis, acetone in the blood, and weight loss >5% of prepregnancy weight
  • In severe cases, liver function tests (LFTs) may be deranged, urinalysis may show ketonuria, and imbalance is noted on serum creatinine and electrolyte measurements

Etiology

  • Etiology is multifactorial
    • Other possible causes include genetic, vestibulo-ocular reflex abnormality, H pylori infection, psychological,hormonal [progesterone, estrogen, human chorionic gonadotropin (hCG), thyroxin, ghrelin, leptin, nesfatin-1, PYY-3]

Signs and Symptoms

  • Symptoms can occur at any time of the day; therefore, the term “morning sickness” is incorrect
    • 95% of patients have symptoms before and after midday and 4% experience symptoms only in the morning
  • Nausea and vomiting in pregnancy (NVP) manifests in a spectrum of severity from mild nausea to very rare life-threatening symptoms
    • Generally a mild, self-limited condition that may be controlled with conservative treatment
    • Only a small percentage of patients have a profound course

Risk Factors

Maternal factors and fetal conditions associated with increased risk of hyperemesis gravidarum:

  • Nulliparity
  • Obesity
  • Young maternal age
  • Increased placental mass (multiple gestation, gestational trophoblastic disease)
  • Triploidy
  • Fetal down syndrome
  • Hydrops fetalis

Other predisposing factors for nausea and vomiting in pregnancy (NVP):

  • Family history or a history of hyperemesis gravidarum in previous pregnancy
  • Increased levels of human chorionic gonadotropin (hCG) and estrogen
  • Medical conditions like migraine and history of motion sickness
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Lower joint replacement risk yet another benefit of statins
Yesterday
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Migraine a risk factor for dementia?
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Daily alcohol intake, certain drugs tied to liver abnormalities in PsA patients
30 Jun 2020
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Pembrolizumab + chemo improves PFS in previously untreated, advanced TNBC
Christina Lau, 5 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.